BioSpace News Archive

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the American Society of Clinical Oncology 2024 Genitourinary Cancers Symposium (ASCO GU) to be held from January 25-27 in San Francisco, California.

DiagnaMed Holdings Corp. today announced the pilot launch of CERVAI™, a world-first consumer brain health and wellness AI solution that aims to ‘raise a red flag’ for potential brain health issues by estimating brain age and providing a brain health score.

Day One Biopharmaceuticals today announced the appointments of Habib Dable and Dr. William Grossman to its Board of Directors.

Enlivex Therapeutics Ltd. today announced that the Israeli Ministry of Health (IMOH) authorized the initiation of a Company-sponsored multi-country, double-blind, randomized, placebo-controlled Phase I/II trial to evaluate the efficacy, safety and tolerability of Allocetra.

FDA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma).

Myomo, Inc. today announced that it has entered into securities purchase agreements with certain new and existing institutional investors as well as certain insiders of the Company for the purchase and sale of 1,578,948 shares of common stock.

Vergent Bioscience announced that new results from the Phase 2 clinical program evaluating the company’s investigational agent VGT-309 will be presented at STS 2024, the 60th Annual Meeting of Thoracic Surgeons, taking place January 27-29, 2024, in San Antonio, Texas.

NRx Pharmaceuticals, Inc. announced that on January 16, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Nasdaq Hearings Panel granted the Company’s request for the transfer of its listing to The Nasdaq Capital Market, subject to the Company evidencing compliance with all applicable criteria for continued listing on the Capital Market tier, including the $35 million in market value of listed securities and the $1.00 bid price requirements.